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Objective: To report the repair of thoracoabdominal aortic aneurysms (TAAAs) with fenestrated and branched endovas-
cular stent grafts (EVSGs).
Methods: Four patients with asymptomatic TAAAs were treated with custom-designed Zenith fenestrated and branched
EVSGs. Three patients had undergone previous open aortic aneurysm repair. Thirteen visceral vessels in four patients
were targeted for incorporation by graft fenestrations and branches.
Results: The fenestration/orifice interface was secured with balloon-expandable Genesis stents or Jostent stent grafts in
9 of 13 target vessels. Completion angiography demonstrated antegrade perfusion in 12 of 13 target vessels. One renal
artery occluded because of graft rotation during deployment. There were no endoleaks. Three patients required
additional surgical procedures related to access vessels. One patient required reoperation for bleeding from an
extra-anatomic bypass graft and subsequently died from multisystem organ failure. Three patients made an uncompli-
cated recovery. No patient developed spinal cord ischemia. Computed tomography at 12 months in the 3 survivors
demonstrated complete aneurysm exclusion with antegrade perfusion in all 10 target vessels.
Conclusions: TAAA repair with fenestrated and branched EVSGs is feasible and provides an acceptable and promising
alternative to conventional surgical repair in selected patients. ( J Vasc Surg 2005;42:600-7.)Open surgical repair of nonruptured thoracoabdominal
aortic aneurysms (TAAA) is associated with an operative
mortality rate of 4% to 16% in specialist centers and has an
average mortality rate of 22% in the United States. Signifi-
cant morbidity occurs in more than 50% of patients: cardiac
complications, acute renal failure, hemorrhage, and spinal
cord ischemia (SCI) each affect 10% to 15% of patients, and
20% to 30% develop pulmonary complications.1,2 Two
endovascular techniques have been proposed as alternatives
to open surgical repair of TAAA. Hybrid open/endovascu-
lar repair has been described3-10 whereby laparotomy and
extra-anatomic surgical revascularization of the visceral ves-
sels precedes endoluminal repair of the entire thoracoab-
dominal aorta. Endovascular repair of juxtarenal and supra-
renal abdominal aortic aneurysms (AAAs) with preservation
of visceral perfusion by fenestrated11-18 or branched19 en-
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600dovascular stent grafts (EVSG) has been shown to be
feasible, and, using similar technology, several authors have
described total endovascular repair of complex thoracic
aortic disease. Inoue et al20 used a branched EVSG to
maintain perfusion of the celiac axis in a patient with a distal
type I endoleak after previous endoluminal repair of a
descending thoracic aortic pseudoaneurysm, and Bleyn et
al21 used a similar technique to preserve perfusion of the
celiac axis in a patient with a Crawford extent I TAAA. In
contrast, Stanley et al15 reported endovascular repair of a
descending thoracic aortic aneurysm with graft fenestration
for the celiac axis to increase the distal attachment zone.
Until now, Chuter et al22,23 had reported the only patient
to have undergone total endovascular repair of TAAA with
preservation of all four visceral vessels by using a multi-
branched EVSG. Using endovascular techniques similar to
those previously described in patients with juxtarenal
AAA,14 together with advances in graft design, we have
extended our indications for endovascular repair to patients
with TAAA.
METHODS
Patients. Between April and October 2003, four pa-
tients underwent endovascular repair of asymptomatic non-
ruptured TAAAs under the care of the principal author
(J.L.A.). Informed consent was obtained from all patients.
Aneurysm assessment and graft design. High-resolution
spiral computed tomographic angiography (CTA) was per-
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ies (CFAs). Axial images were reconstructed at 1-mm
intervals throughout the visceral segment of the aorta.
Transfemoral digital subtraction angiography (DSA) with a
calibrated catheter was performed in all patients. Custom-
designed Zenith endoluminal prostheses were used in all
patients (William A. Cook Australia Pty Ltd, Brisbane,
Australia).14 Graft design and manufacturing techniques
were based on the standard fenestrated EVSG technology
that is now well established and has been used in more than
800 cases of AAA with short infrarenal necks. Each device
was custom-designed to match the anatomy of the specific
patient. Measurement of the aortic diameter and angula-
tion, the ostial diameter of each visceral vessel, the relative
distance of the visceral vessels from a fixed landmark, and
the orientation of each visceral vessel from an aortic cross
section were essential for accurate graft planning and de-
sign. Because more fenestrations were often required than
with a standard fenestrated EVSG for AAA, design assis-
tance was given by the Cook (Australia) Zenith Endovas-
cular Graft Planning Service, which has personnel with the
knowledge and experience of how the fenestrations can be
placed to fit within the confines of the self-expanding stents
used in the manufacture of these devices.
A tubular module with graft fenestrations for the target
vessels was designed for deployment within the visceral
segment of the aorta. Diameter-reducing restraining ties
were placed along the posterior aspect of this module to
limit the initial expansion of the graft after sheath with-
drawal, thereby reducing the device profile and increasing
longitudinal and axial maneuverability. Graft fenestrations
and branches were placed to match the target vessel ostia
that would be crossed by the graft. Side branches were
designed only if there was significant space within the aortic
lumen to allow deployment. Radiopaque markers were
incorporated at quarter-hour positions around the fenestra-
tion or branch to facilitate accurate alignment with the
vessel ostia. The most important modification from the
standard fenestrated EVSG was the addition of a nitinol
reinforcing ring to the fenestrations to aid in seal and
security when a stent graft was introduced to form a side
branch. Anterior and posterior markers were placed on the
body of the graft to facilitate correct axial alignment. Other
customized modular components were designed as re-
quired.
Normal construction, packing, and sterilization times
are approximately 3 to 5 weeks from the signing-off on an
agreed design. The devices for this application are not
registered for general sale and are supplied in Australia
under the provisions allowable by the regulatory body as a
“Custom Made Device.” In Australia to date, the pricing
has been based on the standard registered fenestrated AAA
graft, but this may be adjusted depending on the complex-
ity of the device.
Implantation technique. All procedures were per-
formed with patients under general anesthesia in a dedi-
cated angiography suite by using high-resolution imaging
(Advantx; GE Medical Systems, Milwaukee, Wis). Preop-erative and postoperative N-acetyl cysteine and periopera-
tive aminophylline infusion were used for renal protection.
Cerebrospinal fluid drainage was not used.
After systemic heparinization, the fenestrated module
of the EVSG was oriented extracorporeally and then in-
serted through the access vessel over a superstiff 0.035-
inch Lunderquist wire and positioned in relation to the
visceral vessels. Axial orientation was obtained by aligning
the anteroposterior markers on the body of the graft.
Alignment of multiple markers at the joints of the Z stents
ensured that the EVSG was not twisted. With the image
intensifier positioned craniocaudally perpendicular to the
visceral aorta, the delivery sheath was withdrawn, and the
upper graft stents were released, with the anchoring stent
remaining capped. Alignment of the radiopaque graft
markers, reference to the digital graft image and graft plan,
and intraprocedural DSA ensured that the fenestrations or
branches were aligned axially and longitudinally with the
target vessels. The delivery sheath was then withdrawn to
deploy the device completely. At this stage, the device
remained attached to the delivery sheath by the diameter-
reducing restraining ties, the top cap restraining the prox-
imal anchoring stents, and the distal anchoring wire. No
further graft rotation was possible.
The visceral vessels were next cannulated from the con-
tralateral CFA by using steerable catheter-guidewire systems
from within the endograft lumen. Glyceryl trinitrate was in-
jected into each visceral artery after catheterization to prevent
spasm during manipulations. A 4-cm-long Opta angioplasty
balloon (Cordis Corporation, Miami Lakes, Florida) with a
Fig 1. Optimal alignment of the graft fenestrations and branch
vessels is achieved by inflating angioplasty balloons in the celiac
axis, superior mesenteric artery, and both renal arteries fromwithin
the endograft lumen.diameter matched to the visceral vessel diameter was
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to 4 atm to ensure accurate alignment of the graft fenestra-
tions and vessel ostia. With the balloons inflated to guide
the graft fenestrations or branches to the vessel ostia, the
wire tethering the diameter-reducing restraining ties was
removed to fully expand the EVSG. The top cap was then
deployed, followed by release of the distal anchoring wire
(Fig 1). The delivery system was then retrieved. The image
intensifier was angled appropriately to ensure accurate
alignment of the fenestration markers and visceral artery
origins for stent deployment within the target vessels. If
there was contact between the graft material and the wall of
the aorta, then the interface between the graft fenestration
and the target vessel was secured with a balloon-expandable
Genesis stent (Cordis) sized to match the diameter of the
target vessel. If there was no contact between graft and
aorta or if significant intraluminal thrombus was present,
then a balloon-expandable Jostent stent graft (Abbott Lab-
oratories, Abbott Park, Illinois) was used to bridge the gap
and secure the graft fenestration/target vessel interface.
During deployment of the Jostent stent graft, there is a
relative shortening of the middle layer of polytetrafluoro-
ethylene compared with the inner and outer uncovered
stents. Two thirds of the stent was deployed within the
target vessel, with one third in the endograft lumen, and
the luminal segment of the stent was flared by using larger
angioplasty balloons. The body of the EVSG was then
dilated; inflation of the balloon over the visceral stents was
avoided. Further nonfenestrated modular components
were deployed as required.RESULTS
Case 1. An 82-year-old man presented with a 60-mm-
diameter asymptomatic TAAA. Comorbidity consisted of
hypertension (HT), ischemic heart disease, and stenting of
a left renal artery stenosis. Previous surgery included coro-
nary artery bypass grafting and open repair of a ruptured
Fig 2. Diagramatic representation
of aneurysmmorphology in patients
1 to 4.
Fig 3. Custom-designed Zenith fenestrated and branched stent
grafts inserted in patients 1 to 4.
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ously. The patient was assessed as American Society of
Anesthesiologists (ASA) grade III. Preoperative CTA and
DSA demonstrated occlusion of the celiac axis at its origin
with antegrade flow in the superior mesenteric artery
(SMA) and good back-filling of the branches of the celiac
axis. The SMA and both renal arteries originated from the
aneurysmal aorta (Fig 2). The aortic diameter at the prox-
imal and distal implantation sites was 34 and 20 mm,
respectively. A one-piece EVSG with three fenestrations to
accommodate the SMA (8 mm diameter) and both renal
arteries (6 mm diameter) was constructed (Fig 3). The
EVSG had a proximal and distal diameter of 40 and 28mm,
respectively, and the diameter at the level of the visceral
vessels was 36 mm.
Both CFAs were exposed surgically, and the EVSG was
delivered through a 20F sheath in the right CFA. Graft
maneuverability was significantly limited by the fact that
one third of the previously inserted left renal artery stent
protruded into the aortic lumen. The SMA and right renal
artery were successfully cannulated, but apposition of the
left renal artery graft fenestration and the left renal artery
stent proved impossible. Graft rotation occurred during
deployment and resulted in occlusion of the left renal artery
and dissection and occlusion of the right common iliac
artery. The interface between the graft fenestrations and
Fig 4. Follow-up computed tomographic angiography in patient
2 demonstrating aneurysm exclusion and patent celiac axis, supe-
rior mesenteric artery, and both renal arteries.the SMA and the right renal artery orifices were securedwith 8-mm-diameter Jostent stent grafts. A 28-mm-
diameter Zenith aortouni-iliac EVSG was deployed within
the customized EVSG via the left CFA, and an 8-mm
polytetrafluoroethylene left to right femorofemoral cross-
over graft was inserted. Completion angiography demon-
strated no endoleak and antegrade perfusion of the SMA
and right renal artery. The total procedural time was 10
hours. The patient received a total of 9000 IU of intrave-
nous heparin and 300 mL of contrast medium, and five
units of packed red cells were transfused. Within 24 hours
of the procedure, the patient had a major hemorrhage from
the left groin anastomosis of the crossover graft and re-
turned to the operating room for control of bleeding. The
patient died on the second postoperative day from multi-
system organ failure.
Case 2. A 76-year-old man presented with a 60-mm-
diameter asymptomatic TAAA. Comorbidity consisted of
mild renal impairment with a serum creatinine of 150
mol/L. The patient was assessed as ASA grade II. CTA
and DSA demonstrated a patent celiac axis, SMA, and both
renal arteries originating from the aneurysmal aorta (Fig 2).
A three-piece EVSG was constructed. The aortic diameter
at the proximal and distal implantation sites was 34 and 26
mm, respectively. The fenestrated component included
three fenestrations to accommodate the SMA (8 mm diam-
eter) and both renal arteries (6 mm diameter) and an
8-mm-diameter, 4-mm-long branch for the celiac axis (Fig
3). The fenestrated component had a proximal and distal
diameter of 36 and 28 mm, respectively, and the diameter
at the level of the visceral vessels was 36 mm. Both CFAs
Fig 5. Follow-up computed tomographic angiography in patient
2 demonstrating patent celiac axis, superior mesenteric artery, and
both renal arteries.were exposed surgically, and the EVSG was delivered
JOURNAL OF VASCULAR SURGERY
October 2005604 Anderson et althrough a 22F sheath in the right CFA. The fenestrated
component was deployed first in a satisfactory position.
Minimal aortic thrombus was present at the level of the
SMA and renal arteries, and the graft diameter was suffi-
cient (36 mm) to ensure good apposition with the aortic
wall. The interface between the graft fenestrations and the
SMA and both renal artery orifices were, therefore, secured
with 8- and 6-mm-diameter Genesis stents, respectively.
Perfusion of the celiac axis was maintained by the graft side
branch and an 8-mm-diameter Jostent stent graft. A secondnonfenestrated thoracic EVSG (40 mm proximal diameter
and 36 mm distal diameter) was deployed distal to the left
subclavian artery, and a third EVSG (36 mm proximal and
distal diameters) was deployed to bridge the gap between
the first two stent grafts. Completion angiography demon-
strated no endoleak and antegrade perfusion in all four
branch vessels. Four sheaths had been inserted in the left
CFA, which occluded at the end of the procedure, and
surgical thrombectomy was required. The total procedural
time was 6 hours. The patient received a total of 7000 IU
Fig 6. Percutaneous approach to en-
dovascular thoracoabdominal aortic
aneurysm repair in patient 4.
Fig 7. Follow-up computed tomo-
graphic angiography in patient 4
demonstrating aneurysm exclusion
and patent celiac axis, superior mes-
enteric artery, and both renal arteries.
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No blood transfusion was required. The patient made an
uncomplicated recovery and was discharged home on the
fifth postoperative day. Postoperative creatinine improved
to 130 mol/L. CTA at 1 and 12 months demonstrated
complete aneurysm exclusion with antegrade perfusion in
all four branch vessels (Figs 4 and 5).
Case 3. A 62-year-old woman presented with a 55-
mm-diameter asymptomatic TAAA. Comorbidity included
HT, warfarin therapy, chronic obstructive pulmonary disease,
and renal impairment (serum creatinine, 230 mol/L). Pre-
vious surgery included aortic valve replacement, replace-
ment of the ascending aorta and aortic arch, left subclavian
to carotid artery transposition, and repair of the proximal
descending thoracic aorta for thoracic aortic dissection.
The patient had also required hysterectomy and right ure-
teric diversion with radical pelvic radiotherapy for gyneco-
logic malignancy. The patient was assessed as ASA grade
III. CTA and DSA demonstrated a patent celiac axis orig-
inating 5 mm below the aneurysm, with the SMA and both
renal arteries arising from nonaneurysmal aorta (Fig 2).
The aortic diameter at the proximal and distal implantation
sites was 25 and 19 mm, respectively. A three-piece EVSG
was constructed. The fenestrated component of the EVSG
included a single 20-mm-wide, 18-mm-high scallop to
accommodate the celiac axis (Fig 3). The fenestrated com-
ponent had a proximal and distal diameter of 42 and 26
mm, respectively, and the diameter at the level of the
scallop was 26 mm.
Small-caliber external iliac arteries and dense scarring in
the left groin from multiple previous cannulations for car-
diopulmonary bypass precluded the insertion of the deliv-
ery sheath. The left common iliac artery was therefore
exposed by an extraperitoneal approach, and a 10-mm
Dacron graft (DuPont, Wilmington, Del) was sutured end
to side to the artery. The EVSG was delivered through a
22F sheath via the Dacron graft. A percutaneous approach
was used to the right CFA. The first nonfenestrated tho-
racic EVSG (30-mm proximal diameter and 42-mm distal
diameter) was deployed distal to the left subclavian artery,
followed by a second EVSG (42-mm proximal and distal
diameters) and, finally, the fenestrated component. The
graft was deployed in a satisfactory position, and the celiac
axis was not stented. Completion angiography demon-
strated no endoleak with antegrade perfusion of the celiac
axis and SMA. The total procedure time was 6.5 hours. The
patient received a total of 5000 IU of intravenous heparin
and 345 mL of contrast medium, and four units of packed
red cells were transfused. The patient made an uncompli-
cated recovery and was discharged home on the sixth
postoperative day. CTA at 1 and 12 months demonstrated
complete aneurysm exclusion with antegrade perfusion in
the celiac axis and SMA.
Case 4. A 75-year-old man presented with an 85-mm-
diameter asymptomatic TAAA. Comorbidity consisted of
HT and chronic obstructive pulmonary disease. Previous
surgery included open repair of nonruptured infrarenal
AAA with an aortoaortic graft 14 years previously and lefthemicolectomy for colonic carcinoma 11 years previously.
The patient was assessed as ASA grade III. CTA and DSA
demonstrated that the celiac axis, SMA, and both renal
arteries originated from the aneurysmal aorta (Fig 2). The
aortic diameter at the proximal and distal implantation sites
was 40 and 22 mm, respectively. A one-piece EVSG with
four fenestrations to accommodate the celiac axis (12-
mm diameter), SMA (10-mm diameter), and both renal
arteries (6 mm wide and 8 mm high) was constructed
(Fig 3). The EVSG had a proximal and distal diameter of 46
and 26 mm, respectively, and the diameter at the level of
the celiac axis and SMA was 46 mm.
A percutaneous approach to both CFAs was used. A
“preclose” technique was used for the right CFA that used
a suture-mediated arterial closure device (Perclose; Abbott
Laboratory, Redwood City, Calif). The EVSG was deliv-
ered through a 24F sheath in the right CFA (Fig 6). The
graft was deployed in a satisfactory position. Three sheaths
were inserted into the left CFA for cannulation of the SMA
and both renal arteries. The interface between the graft
fenestrations and the SMA and the right renal artery orifices
were secured with 10- and 8-mm-diameter Jostent stent
grafts, respectively. Three 28  8-mm Jostent stent grafts
were deployed within a track through the laminated throm-
bus between the graft fenestration and the left renal artery.
Because there was minimal thrombus and good apposition
between the EVSG and the aorta at the level of the celiac
axis, it was not considered necessary to stent the celiac axis
once the graft fenestration/SMA interface had been se-
cured. Completion angiography demonstrated no en-
doleak with antegrade perfusion of all four branch vessels.
The total procedural time was 9 hours. The patient received
a total of 10,000 IU of intravenous heparin and 500 mL of
contrast medium. No blood transfusion was required. The
patient made an uncomplicated recovery and was dis-
charged home on the third postoperative day. CTA at 1
and 12 months demonstrated complete aneurysm exclu-
sion with antegrade perfusion in all four target vessels
(Fig 7).
DISCUSSION
Considerable experience with the use of graft fenestra-
tion techniques for the treatment of juxtarenal AAA14 has
allowed the authors to expand their clinical indications for
endovascular repair to include patients with TAAA. This arti-
cle describes four consecutive patients who underwent endo-
vascular repair of TAAA with fenestrated and branched
EVSGs. Three of the patients (cases 1, 3, and 4) were ASA
grade III and were considered at high risk for conventional
surgical repair. Previous open aortic reconstruction and
extensive aneurysmal disease would have added to the
complexity of open repair and increased the risk of SCI in
these patients. The approach described in this article has
obvious advantages over conventional open repair and hy-
brid open/endovascular techniques in that laparotomy or
thoracotomy and aortic cross-clamping are avoided and
cardiovascular instability, operative blood loss, and visceral
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however, is that this technique does not facilitate preserva-
tion of flow to the intercostal arteries, and this may be
associated with an increased risk of SCI. In contrast, other
factors that contribute to SCI are avoided, such as pro-
longed lower torso and visceral ischemia and reperfusion
and cardiovascular instability. Despite these considerations,
the first reported case of total endovascular repair of TAAA,
by Chuter et al,22,23 was complicated by SCI. Adjuvant
techniques for spinal cord protection were not used in the
present series because of a lack of clinical experience. None
of the patients in this series had evidence of postoperative
SCI.
Minor refinements in endovascular technique were re-
quired in this series. In patients with juxtarenal AAA,
transgraft catheterization and balloon inflation within the
renal arteries alone is sufficient to ensure accurate align-
ment of the graft fenestrations and vessel ostia before full
graft deployment. Two patients in this series had grafts with
four fenestrations, and catheterization of all four visceral
vessels was considered necessary to ensure accurate graft
alignment and prevent branch vessel occlusion. To prevent
proximal type I endoleak, Jostent stent grafts were used to
seal the fenestration/vessel orifice interface if there was no
contact between the graft and the vessel or if significant
laminated intraluminal thrombus was present. In the fourth
patient in the series, three overlapping 28  8-mm Jostent
stent grafts were required to bridge the gap through the
thrombus from the graft fenestration to the left renal artery.
These stent grafts have excellent early patency rates in the
treatment of renal artery lesions,24 but their long-term
patency in visceral arteries is unknown. Stent graft migra-
tion and subsequent branch vessel occlusion during sac
remodeling has been shown to be a potential problem with
thoracic aortic EVSGs.15 In patients with extensive thoracic
aneurysmal disease, considerable overlapping of the tho-
racic EVSGs is recommended to minimize stent graft mi-
gration. The technique of flaring of the luminal segment of
the branch vessel stents is intended to add increased secu-
rity to the fixation at the fenestration/orifice interface and
also improves ease of access to the vessel for further endo-
vascular intervention should this be required. The presence
of a renal artery stent protruding into the aortic lumen
caused considerable technical difficulties in our first patient
and resulted in occlusion of the renal artery, conversion to
an aortouni-iliac EVSG and femorofemoral crossover graft,
and, ultimately, death as a consequence of graft hemor-
rhage.
To our knowledge, this study includes the first uncom-
plicated cases of TAAA repair with preservation of all four
visceral vessels by fenestrated and branched EVSGs, as well
as the first case of endovascular TAAA repair by an entirely
percutaneous approach. CTA at 12 months’ follow-up in
the 3 survivors has demonstrated complete aneurysm ex-
clusion, with reductions in aneurysm diameter and ante-
grade perfusion in all 10 target vessels. The efficacy anddurability of the technique will require corroboration in
larger clinical series. High-quality preoperative imaging for
graft customization, advanced graft design, high-resolution
intraoperative imaging, excellent catheter skills, and careful
clinical and radiologic follow-up are essential for the suc-
cessful treatment of these complex aneurysms. This study
has demonstrated that endovascular repair of TAAA is
feasible and that it provides an acceptable and promising
alternative to conventional surgical repair in selected pa-
tients. With advances in graft technology and increasing
experience, endovascular repair may become the optimal
treatment for patients with these challenging lesions.
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